US Broker Ratings

Solventum Corporation (SOLV) Stock Analysis: Navigating Potential Upside in the Healthcare Sector

Solventum Corporation (SOLV), a key player in the healthcare sector, presents intriguing opportunities for investors seeking exposure to the medical instruments and supplies industry. With a market capitalization of $14.08..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth with Strategic Partnerships in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, has positioned itself as a formidable player in the medical distribution industry. With a market cap of $10 billion,..

Quest Diagnostics (DGX) Stock Analysis: A 6.29% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the U.S. healthcare diagnostics sector, stands as a compelling consideration for investors seeking exposure to a robust industry with consistent demand...

Insulet Corporation (PODD) Stock Analysis: Strong Buy Ratings and Potential 45.20% Upside

Insulet Corporation (NASDAQ: PODD) is making waves in the healthcare sector, specifically within the medical devices industry, with its innovative insulin delivery systems. As diabetes management continues to be a..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring Growth Potential and Analyst Sentiment

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $26.47 billion, this Swiss-based..

Waters Corporation (WAT) Stock Analysis: Unveiling a 11.96% Potential Upside with Strong Buy Ratings

Waters Corporation, trading under the ticker WAT, stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Milford, Massachusetts, the company commands..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 13.4% Potential Upside Amid Strong Healthcare Performance

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with a compelling blend of stability and growth potential. Operating within the Medical..

Gilead Sciences, Inc. (GILD): Investor Outlook on Robust Earnings and Promising Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, continues to capture investor interest with its impressive market capitalization of $166.72 billion. Known for its innovative approach..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Healthcare Landscape with Strategic Resilience

Molina Healthcare Inc (NYSE: MOH), a stalwart in the U.S. healthcare sector, stands as a critical player in providing managed healthcare services. With a market capitalization of $11.74 billion, Molina..

Incyte Corporation (INCY) Stock Analysis: Navigating Growth in the Biotech Sector with a 20.9% Revenue Surge

As biotech continues to dominate the healthcare sector, Incyte Corporation (NASDAQ: INCY) stands out with its robust pipeline and impressive revenue growth. With a market capitalization of $23.42 billion, Incyte..

Novartis AG (NVS) Stock Analysis: Healthcare Giant with Promising Stability and Steady Dividend Yield

Novartis AG (NVS), a titan in the healthcare sector, continues to be a pivotal player in the pharmaceutical industry. Headquartered in Basel, Switzerland, the company is renowned for its innovative..

DaVita Inc. (DVA) Stock Analysis: Examining Growth Potential Amid a Robust Market Position

DaVita Inc. (NYSE: DVA), a stalwart in the healthcare sector, is making waves with its impressive trajectory in the medical care facilities industry. With a market capitalization of $15.21 billion,..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Exploring 21% Potential Upside for Investors

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has long been a prominent player in the biotechnology sector, a segment of the healthcare industry renowned for innovation and growth. With a market capitalization..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising 17.18% Upside in the Thriving Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) stands out in the healthcare sector with its robust pipeline of innovative pharmaceuticals targeting neurological, psychiatric, endocrine, and immunological disorders. With a market capitalization of $17.18..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Collaborations

Exelixis, Inc. (NASDAQ: EXEL) continues to capture the interest of investors with its robust footprint in the biotechnology sector, particularly in the oncology niche. With a market capitalization of $14.06..

The Cigna Group (CI)

⚠️ No article content returned.

..

STERIS plc (STE) Stock Analysis: Unlocking a Potential 17.91% Upside in the Healthcare Sector

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, offers infection prevention products and services across the globe. As the company continues to expand its footprint in the..

Align Technology, Inc. (ALGN) Stock Analysis: Potential 18% Upside with Strong Analyst Support

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector and a pivotal player within the medical instruments and supplies industry, has been capturing investor attention not only for..

Medtronic plc (MDT) Stock Analysis: A Healthcare Giant with a 17.6% Upside Potential

Medtronic plc (NYSE: MDT), a leading name in the healthcare sector, stands as a formidable player in the medical devices industry. With a market capitalization of $106.5 billion, the company’s..

Illumina, Inc. (ILMN) Stock Analysis: Revenue Growth and Strategic Collaborations Highlight Potential Amidst Valuation Concerns

Illumina, Inc. (ILMN), a pioneering entity in the healthcare sector, stands out in the diagnostics and research industry for its sequencing and array-based solutions. With a substantial market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds